Gene therapy for murine glycerol kinase deficiency: Importance of murine ortholog

Biochemical and Biophysical Research Communications

Volumn 335, Issue 1, 2005, Pages 247-255

  Kuwada, N ^a,b   Nagano, K ^a,b   MacLennan, N ^a   Havens, J ^a,c   Kumar, M ^a,d   Dipple, K M ^a   McCabe, E R B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acidemia; Adenovirus; Gene therapy; Glycerol kinase; Glycerol kinase deficiency; Glycerol metabolism; Hypoglycemia; Murine models

Indexed keywords

GLYCEROL KINASE;

ACIDEMIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE CONSTRUCT; GENE REPLACEMENT THERAPY; GENE THERAPY; GLYCEROL KINASE DEFICIENCY; HUMAN; HYPOGLYCEMIA; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL RATE; X CHROMOSOME;

ADENOVIRIDAE; ANIMALS; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; BODY WEIGHT; FATTY ACIDS, NONESTERIFIED; GENE THERAPY; GLYCEROL; GLYCEROL KINASE; MICE; MICE, KNOCKOUT; SURVIVAL RATE;

ADENOVIRIDAE; MURINAE;

EID: 25144491683     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.066     Document Type: Article

References (26)

1. E. McCabe Disorders of glycerol metabolism C. Scriver A. Beaudet W. Sly D. Valle B. Childs B. Vogelstein Metabolic and Molecular Bases of Inherited Diseases 2001 McGraw-Hill New York 2217 2237
2. A.H. Huq, R.S. Lovell, M.J. Sampson, W.K. Decker, M.B. Dinulos, C.M. Disteche, and W.J. Craigen Isolation, mapping, and functional expression of the mouse × chromosome glycerol kinase gene Genomics 36 1996 530 534
3. W. Guo, K. Worley, V. Adams, J. Mason, D. Sylvester-Jackson, Y.-H. Zhang, J.A. Towbin, D.D. Fogt, S. Madu, D.A. Wheeler, and E.R.B. McCabe Genomic scanning for expressed sequences in xp21 identifies the glycerol kinase gene Nat. Genet. 4 1993 367 372
4. R.A. Robergs, and S.E. Griffin Glycerol. Biochemistry, pharmacokinetics and clinical and practical applications Sports Med. 26 1998 145 167
5. E.I. Ginns, J.A. Barranger, S.W. McClean, C. Sliva, R. Young, E. Schaefer, S.I. Goodman, and E.R. McCabe A juvenile form of glycerol kinase deficiency with episodic vomiting, acidemia, and stupor J. Pediatr. 104 1984 736 739
6. U. Francke, J.F. Harper, B.T. Darras, J.M. Cowan, E.R. McCabe, A. Kohlschutter, W.K. Seltzer, F. Saito, J. Goto, and J.P. Harpey Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions Am. J. Hum. Genet. 40 1987 212 227
7. E.R. McCabe, P.V. Fennessey, M.A. Guggenheim, B.S. Miles, W.W. Bullen, D.J. Sceats, and S.I. Goodman Human glycerol kinase deficiency with hyperglycerolemia and glyceroluria Biochem. Biophys. Res. Commun. 78 1977 1327 1333
8. D.R. Sjarif, R.J. Sinke, M. Duran, F.A. Beemer, W.J. Kleijer, J.K. Ploos Van Amstel, and B.T. Poll-The Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency J. Med. Genet. 35 1998 650 656
9. M.A. Guggenheim, E.R. McCabe, M. Roig, S.I. Goodman, G.M. Lum, W.W. Bullen, and S.P. Ringel Glycerol kinase deficiency with neuromuscular, skeletal, and adrenal abnormalities Ann. Neurol. 7 1980 441 449
10. K.M. Dipple, Y.H. Zhang, B.L. Huang, L.L. McCabe, J. Dallongeville, T. Inokuchi, M. Kimura, H.J. Marx, G.O. Roederer, V. Shih, S. Yamaguchi, I. Yoshida, and E.R. McCabe Glycerol kinase deficiency: evidence for complexity in a single gene disorder Hum. Genet. 109 2001 55 62
11. A.H. Huq, R.S. Lovell, C.N. Ou, A.L. Beaudet, and W.J. Craigen X-linked glycerol kinase deficiency in the mouse leads to growth retardation, altered fat metabolism, autonomous glucocorticoid secretion and neonatal death Hum. Mol. Genet. 6 1997 1803 1809
12. J.G. Strauss, S. Frank, D. Kratky, G. Hammerle, A. Hrzenjak, G. Knipping, A. Von Eckardstein, G.M. Kostner, and R. Zechner Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice J. Biol. Chem. 276 2001 36083 36090
13. X. Ye, B. Whiteman, M. Jerebtsova, and M.L. Batshaw Correction of argininosuccinate synthetase (as) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human as cdna Gene Ther. 7 2000 1777 1782
14. A.P. Walker, F. Muscatelli, A.N. Stafford, J. Chelly, N. Dahl, H.K. Blomquist, J. Delanghe, P.J. Willems, B. Steinmann, and A.P. Monaco Mutations and phenotype in isolated glycerol kinase deficiency Am. J. Hum. Genet. 58 1996 1205 1211
15. C. Hellerud, M. Adamowicz, D. Jurkiewicz, J. Taybert, J. Kubalska, E. Ciara, E. Popowska, J.R. Ellis, S. Lindstedt, and E. Pronicka Clinical heterogeneity and molecular findings in five polish patients with glycerol kinase deficiency: investigation of two splice site mutations with computerized splice junction analysis and xp21 gene-specific mrna analysis Mol. Genet. Metab. 79 2003 149 159
16. C.A. Sargent, A. Kidd, S. Moore, J. Dean, G.T. Besley, and N.A. Affara Five cases of isolated glycerol kinase deficiency, including two families: failure to find genotype:phenotype correlation J. Med. Genet. 37 2000 434 441
17. L.J. Brown, R.A. Koza, L. Marshall, L.P. Kozak, and M.J. MacDonald Lethal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases J. Biol. Chem. 277 2002 32899 32904
18. A. Mian, and B. Lee Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism Trends Mol. Med. 8 2002 583 589
19. V. Adams, L. Griffin, J. Towbin, B. Gelb, K. Worley, and E.R. McCabe Porin interaction with hexokinase and glycerol kinase: metabolic microcompartmentation at the outer mitochondrial membrane Biochem. Med. Metab. Biol. 45 1991 271 291
20. A.K. Ostlund, U. Gohring, J. Krause, and D. Brdiczka The binding of glycerol kinase to the outer membrane of rat liver mitochondria: its importance in metabolic regulation Biochem. Med. 30 1983 231 245
21. M.A. Morsy, J.Z. Zhao, T.T. Ngo, A.W. Warman, W.E. O'brien, F.L. Graham, and C.T. Caskey Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes J. Clin. Invest. 97 1996 826 832
22. X. Ye, K.P. Zimmer, R. Brown, C. Pabin, M.L. Batshaw, J.M. Wilson, and M.B. Robinson Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors Hum. Gene Ther. 12 2001 1035 1046
23. J. Walter, Q. You, J.N. Hagstrom, M. Sands, and K.A. High Successful expression of human factor ix following repeat administration of adenoviral vector in mice Proc. Natl. Acad. Sci. USA 93 1996 3056 3061
24. C.E. Thomas, A. Ehrhardt, and M.A. Kay Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4 2003 346 358
25. X. Xiao, J. Li, and R.J. Samulski Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J. Virol. 70 1996 8098 8108
26. M.S. Sun, C.J. Pan, J.J. Shieh, A. Ghosh, L.Y. Chen, B.C. Mansfield, J.M. Ward, B.J. Byrne, and J.Y. Chou Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type ia in mice Hum. Mol. Genet. 11 2002 2155 2164